Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 168.00
Bid: 167.80
Ask: 168.00
Change: 3.60 (2.19%)
Spread: 0.20 (0.119%)
Open: 167.00
High: 168.20
Low: 165.40
Prev. Close: 164.40
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Apr 2018 13:14

RNS Number : 4279M
Forterra plc
27 April 2018
 

27 April 2018

Forterra plc

PDMR Shareholdings

Forterra plc (the "Company") was notified on 26 April 2018 that on the same day Matthew Clay, Managing Director, Bespoke Products and Darren Rix, Strategy and Development Director both of whom are defined as Persons Discharging Management Responsibilities (PDMR's) exercised share options over the Company's ordinary shares of 1p each ("ordinary shares") granted under the Forterra Deferred Annual Bonus Plan.

The options were granted as nominal (1p) cost options although this sum was waived by the Company on exercise. The number of options exercised also includes a dividend equivalent in addition to the options initially granted in accordance with the rules of the scheme. On exercise, sufficient shares were immediately sold to cover tax, NI and transaction costs.

No new shares were issued in respect of these transactions with the shares being transferred to the individuals from the Forterra Employee Benefit Trust.

Name

Number of options exercised

Number of shares transferred to individual after paying tax, NI and transaction costs

Number of shares now beneficially held by individual

Matthew Clay

18,779

9,921

9,921

Darren Rix

11,768

6,217

6,217

 

 

Enquiries

 

Forterra plc:

+44 (0) 1604 707 600

Shatish Dasani (CFO)

Ben Guyatt (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Matthew Clay

2.

Reason for the notification

a)

Position/status

Managing Director Bespoke Products (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 18,779 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 8,858 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (9,921) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

18,779

(ii) Sale

£3.06

8,858

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

18,779

Nil

 (ii) Sale

£3.06

8,858

£27,105.48

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Darren Rix

2.

Reason for the notification

a)

Position/status

Strategy and Development Director (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 11,768 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 5,551 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (6,217) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

11,768

(ii) Sale

£3.06

5,551

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

11,768

Nil

 (ii) Sale

£3.06

5,551

£16,986.06

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUCGCUPRGPM
Date   Source Headline
8th Jul 20203:02 pmRNSHolding(s) in Company
8th Jul 202010:32 amRNSHolding(s) in Company
7th Jul 20203:27 pmRNSHolding(s) in Company
7th Jul 20203:25 pmRNSHolding(s) in Company
7th Jul 20202:20 pmRNSTotal Voting Rights and Capital
7th Jul 202012:44 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHolding(s) in Company
6th Jul 20203:34 pmRNSDirector Shareholdings
6th Jul 20203:32 pmRNSPCA Shareholdings
2nd Jul 20207:00 amRNSResults of Placing
1st Jul 20204:41 pmRNSProposed placing of new ordinary shares
1st Jul 20204:40 pmRNSFinancing update and proposed equity placing
25th Jun 202010:44 amRNSHolding(s) in Company
24th Jun 20208:02 amRNSHolding(s) in Company
22nd Jun 20203:27 pmRNSHolding(s) in Company
16th Jun 20207:55 amRNSHolding(s) in Company
10th Jun 202012:53 pmRNSHolding(s) in Company
10th Jun 202012:45 pmRNSHolding(s) in Company
3rd Jun 20207:00 amRNSTrading Update
26th May 20202:25 pmRNSDirector/PDMR Shareholding
14th May 20201:45 pmRNSResult of AGM
14th May 202012:08 pmRNSSecond Price Monitoring Extn
14th May 202012:02 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSRecommencement of operations
16th Apr 202012:07 pmRNSSecond Price Monitoring Extn
16th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20207:00 amRNSAnnual Report 2019 and AGM 2020
26th Mar 20209:07 amRNSHolding(s) in Company
24th Mar 20202:50 pmRNSUpdate on Covid-19
24th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20205:41 pmRNSDirector/PDMR Shareholding
13th Mar 20209:55 amRNSHolding(s) in Company
13th Mar 20209:51 amRNSDirector/PDMR Shareholding
10th Mar 20207:00 amRNS2019 FULL YEAR RESULTS
3rd Mar 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Feb 20209:23 amRNSHolding(s) in Company
6th Feb 202010:59 amRNSEmployee Benefit Trust Share Purchase
30th Jan 20202:10 pmRNSHolding(s) in Company
28th Jan 20203:47 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
16th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20204:51 pmRNSEmployee Benefit Trust Share Purchase
6th Jan 202011:01 amRNSHolding(s) in Company
2nd Jan 20203:00 pmRNSCompany Secretary Change
2nd Jan 20207:00 amRNSHolding(s) in Company
2nd Jan 20207:00 amRNSHolding(s) in Company
23rd Dec 20194:36 pmRNSHolding(s) in Company
17th Dec 20198:57 amRNSDirector/PDMR Shareholding
16th Dec 20195:42 pmRNSHolding(s) in Company
11th Dec 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.